These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6292084)

  • 1. Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats. Role of the sympathoadrenal system and vasopressin.
    Okuno T; Lindheimer MD; Oparil S
    Hypertension; 1982; 4(6):809-16. PubMed ID: 6292084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central vasopressin in the modulation of catecholamine release in conscious rats.
    King KA; Mackie G; Pang CC; Wall RA
    Can J Physiol Pharmacol; 1985 Dec; 63(12):1501-5. PubMed ID: 3830349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of somatostatin: pressor response, AVP release, and sympathoinhibition.
    Rettig R; Geist R; Sauer U; Rohmeiss P; Unger T
    Am J Physiol; 1989 Sep; 257(3 Pt 2):R588-94. PubMed ID: 2571303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells.
    Wuthrich RP; Vallotton MB
    Am J Physiol; 1986 Sep; 251(3 Pt 2):F499-505. PubMed ID: 3019160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of the sympathetic nervous system in the centrogenic pressor and tachycardiac effects of prostaglandins E2 and F2 alpha in anaesthetised cats.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Brain Res; 1987 Dec; 435(1-2):7-14. PubMed ID: 2827859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.
    Okuno T; Nagahama S; Lindheimer MD; Oparil S
    Hypertension; 1983; 5(5):653-62. PubMed ID: 6311736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension.
    Suzuki H; Saruta T; Ferrario CM; Brosnihan KB
    Jpn Heart J; 1987 May; 28(3):413-26. PubMed ID: 2887673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negligible role of catecholaminergic receptors in the anteroventral third ventricular region in mediating vasopressin-releasing and cardiovascular actions of prostaglandin E2.
    Yamaguchi K; Hama H; Watanabe K
    Exp Brain Res; 1999 Dec; 129(4):532-40. PubMed ID: 10638427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin: mechanism of central cardiovascular action in conscious rats.
    Rohmeiss P; Becker H; Dietrich R; Luft F; Unger T
    J Cardiovasc Pharmacol; 1986; 8(4):689-96. PubMed ID: 2427805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular and antidiuretic effects of central prostaglandin E2.
    Hoffman WE; Schmid PG
    J Physiol; 1979 Mar; 288():159-69. PubMed ID: 469713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat.
    MacNeil BJ; Jansen AH; Greenberg AH; Nance DM
    Brain Behav Immun; 2003 Dec; 17(6):442-52. PubMed ID: 14583236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vasopressin in cardiovascular and neurohormonal responses to intracerebroventricular hypertonic NaCl.
    Kawano Y; Ferrario CM
    Jpn Heart J; 1990 Mar; 31(2):237-44. PubMed ID: 1972413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release.
    Janiak P; Kasson BG; Brody MJ
    Hypertension; 1989 Jun; 13(6 Pt 2):935-40. PubMed ID: 2737730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of hypertension and bradycardia following lesions of the caudal ventrolateral medulla in the rabbit: the role of sympathetic nerves, circulating adrenaline, vasopressin and renin.
    Elliott JM; Kapoor V; Cain M; West MJ; Chalmers JP
    Clin Exp Hypertens A; 1985; 7(8):1059-82. PubMed ID: 2994915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic activation cannot fully account for increased plasma renin levels during water deprivation.
    Blair ML; Woolf PD; Felten SY
    Am J Physiol; 1997 Apr; 272(4 Pt 2):R1197-203. PubMed ID: 9140020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
    Ishikawa S; Schrier RW
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of yohimbine-induced renin release in the conscious rat.
    Pfister SL; Keeton TK
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jan; 337(1):35-46. PubMed ID: 3285225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.